Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Norway

European Innovation Council · Running

HeartVision Illuminating new paths in heart failure therapy

Coordinator
Universitetet I Tromsoe - Norges Arktiske Universitet, Norway
Runs
1 July 2026 to 30 June 2030
Status
Running
EU funding
€4.0m
Total cost
€4.0m
Partners
7 organisations in 4 countries
Type
European Innovation Council
Grant agreement
101258941

What the project is doing

In the project's own words, from its summary on CORDIS.

HeartVision is an ambitious high-risk, high-gain project that aims to unlock real-time, in vivo 3D microscopy of beating hearts and engineered heart tissues (EHTs) at cell-scale resolution – even deep within tissue folds. Heart failure is the leading cause of death worldwide, and today, there is no curative therapy for it. EHT transplantation offers hope, but we currently lack tools to assess its effectiveness in real time.

Critical questions remain unanswered: Where do transplanted cardiomyocytes go? How do they integrate? When do they start contributing to heart function? Today, even imaging cells deep within therapy-scale EHTs is not possible - let alone in a beating heart. HeartVision will generate multiple IPs with potential in current and future clinical and biotech markets, while ensuring open access to key scientific breakthroughs.

It strikes a bold balance between innovation exploitation and open science dissemination. HeartVision will realize the dream of cell-scale imaging in living organs and put it in the hands of therapy developers, reshaping how we see, study, and treat heart failure and beyond.

Topics

Who is involved

OrganisationCityCountryRole
Universitetet I Tromsoe - Norges Arktiske UniversitetTromsoNorwayCoordinator
Universitaetsklinikum Hamburg-EppendorfHamburgGermanyAssociatedpartner
Centro Nacional De Investigaciones Cardiovasculares Carlos Iii (f.s.p.)MadridSpainParticipant
Universitat De BarcelonaBarcelonaSpainParticipant
Norinnova ASTromsoNorwayThird party
Universitetssykehuset Nord-Norge HfTromsoNorwayAssociatedpartner
University of SouthamptonSouthamptonUnited KingdomParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI